Continental Differences in Clinical Characteristics, Management, and Outcomes in Patients Hospitalized With Worsening Heart Failure. Results From the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) Program

John E.A. Blair, Faiez Zannad, Marvin A. Konstam, Thomas Cook, Brian Traver, John C. Burnett, Liliana Grinfeld, Holly Krasa, Aldo P. Maggioni, Cesare Orlandi, Karl Swedberg, James E. Udelson, Christopher Zimmer, Mihai Gheorghiade

Research output: Contribution to journalArticle

141 Scopus citations

Fingerprint Dive into the research topics of 'Continental Differences in Clinical Characteristics, Management, and Outcomes in Patients Hospitalized With Worsening Heart Failure. Results From the EVEREST (Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan) Program'. Together they form a unique fingerprint.

Medicine & Life Sciences